In 8 of 16 patients studied, the vaccines activated T cells that recognize the patient’s own pancreatic cancers. These patients also showed delayed recurrence of their pancreatic cancers, suggesting the T cells activated by the vaccines may be having the desired effect to keep pancreatic cancers in check.
Same, this big catchy over optimistic and click bait headlines make me automatically really suspicious of the claims. Great news if the second trial goes well
Good news, but the headline lacks nuance.
Blatant skepticism replaced with cautious optimism
Same, this big catchy over optimistic and click bait headlines make me automatically really suspicious of the claims. Great news if the second trial goes well
Yes, 16 people is not relevant enough for anything.